Latest News Archive
Please select Category, Year, and then Month to display items
20 December 2020
|
Story Thabo Kessah
|
Photo Thabo Kessah
Mbuyiselwa Moloi with student volunteers, Keamogetswe Mooketsi (presenter), Tshumelo Phaladi (producer), and Siphamandla Shabangu (SRC member – Social Justice and Universal Access).
The month of October 2020 marked the first anniversary of the Qwaqwa Campus online student radio, Q-Lit. “It has been a rocky road of sleepless nights, tears, and a lot of challenges. However, we have grown from strength to strength. We have made dreams of ordinary students possible. We have influenced change and inspired students to tap into their talents and potential,” said an elated station manager, Mbuyiselwa Moloi.
The station came in handy during the worst lockdown period of the COVID-19 pandemic when it bridged the communication gap between students and the university to integrate teaching and learning into the programming to ensure that no student was left behind. “With all of the regulations and online learning, Q-Lit had to be reinvented. While it was not an easy journey, we have grown more than ever before. Our August 2020 report shows that we have pulled in more than 1 600 listeners, even amid the learning, unlearning, and relearning processes. It was during this month that we also ran a series highlighting strategic offices led by women on campus as part of our Women’s Month celebration,” Mbuyiselwa revealed.
Looking to the future, the station hopes to obtain a full broadcasting licence from the regulatory body, the Independent Communication Authority of South Africa (ICASA), soon.
DNA sequencer launched at the UFS
2013-11-25
 |
| Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them. |
The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.
The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.
The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.
The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.
The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.
“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.
Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”